Welcure Drugs & Pharmaceuticals Ltd
Welcure Drugs & Pharmaceuticals Ltd Live Price Chart
Performance
| Previous Close | ₹ 0.23 |
| High | ₹ 0.25 |
| Volume | 5720019 |
| 52W Range | ₹ 0.19 - ₹ 0.96 |
| Open | ₹ 0.23 |
| Low | ₹ 0.23 |
| Market Cap | ₹ 29.66 Cr |
Welcure Drugs & Pharmaceuticals Ltd Technicals
| 20 Day | ₹ 0.231 |
| 50 Day | ₹ 0.242 |
| 100 Day | ₹ 0.271 |
| 200 Day | ₹ 0.353 |
| 20 Day | ₹ 0.228 |
| 50 Day | ₹ 0.241 |
| 100 Day | ₹ 0.264 |
| 200 Day | ₹ 0.323 |
Welcure Drugs & Pharmaceuticals Ltd Fundamentals
| ROCE | -5.659 |
| P/E Ratio | -5.750 |
| P/B Ratio | 0.290 |
| Industry P/E | 0.290 |
| Debt to Equity | 70.393 |
| ROE | -5.659 |
| EPS | -0.040 |
| Dividend Yield | 0.000 |
| Book Value | 0.785 |
| Face Value | 1.000 |
Welcure Drugs & Pharmaceuticals Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 26.4599 | 0.0939 | 0.2371 | 0.105 | 0.1335599 |
| Total Expenses | 23.6798 | 0.2687 | 0.1354 | 0.0814207 | 0.0784122 |
| Profit After Tax | 2.1701 | -0.1748 | 0.1017 | 0.0235793 | 0.0551477 |
Welcure Drugs & Pharmaceuticals Ltd Shareholding Pattern
| Promoter Holdings | 0.000 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 95.626 % |
| Others - | 4.375 % |
About Welcure Drugs & Pharmaceuticals Ltd
Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain. The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL). The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations. It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen. It manufactures over a hundred varieties of tablets, capsules and dry syrups, sulpha drugs, vitamins, analgesics, etc. Its subsidiary, AKL, manufactures 6-APA, a key drug intermediate in the manufacture of semi-synthetic penicillin. The company has decided to set up new sections of paediatrics and veterinary drugs and to diversify into ointments and liquid syrups. The new products of the company WELSTAP , X- CLOX , ETHAMBUTOL, RIFA- Z , CETIRIZIN , NORTIN have been well accepted in the market. The Company has entered into a collaboration agreement with a russian company to act as their sole selling agent for a unique medici ...
Similar Stocks
| Aegis Logistics Ltd Trading | ₹ 1,270.55 -15.6 (-1.21%) |
| Utique Enterprises Ltd Trading | ₹ 3.96 +0.06 (+1.54%) |
| Computer Point Ltd Trading | ₹ 3.49 +0.01 (+0.29%) |
| FGP Ltd Trading | ₹ 14.50 +0.59 (+4.24%) |
| Kothari Industrial Corporation Ltd Trading | ₹ 133.65 -3.7 (-2.69%) |
| Modella Woollens Ltd Trading | ₹ 72.00 +1 (+1.41%) |
FAQs on Welcure Drugs & Pharmaceuticals Ltd
1. Can I buy Welcure Drugs & Pharmaceuticals Ltd from PL Capital? ›
2. Does Welcure Drugs & Pharmaceuticals Ltd pay dividends? ›
3. What is the current share price of Welcure Drugs & Pharmaceuticals Ltd ? ›
4. What is the 52-week high and low of Welcure Drugs & Pharmaceuticals Ltd ? ›
Start SIP in Welcure Drugs & Pharmaceuticals Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
